Beyond E-Prescribing: How Infrastructure for the Entire Prescription Lifecycle Can Reduce Friction at Scale Nationwide

In today’s healthcare environment, the prescription experience is often complex and difficult to navigate. While electronic prescribing has expanded significantly, the path from doctor to pharmacy to patient can still involve delays, administrative hurdles, and coordination challenges. Healthcare providers note that manual processes and regulatory requirements add friction to daily workflows. “Many healthcare leaders see the challenge as more than a technology issue. It also raises broader questions about how prescription infrastructure has evolved over time,” says Nabil Hallak, co-founder and Chief Operating Officer of TransferMyRx. 

For Nabil, the core issue is the need for connected rails that let all participants in the prescription ecosystem move in harmony. According to him, the goal is to build a system that modernizes the full lifecycle of a prescription from the moment it’s written to when the patient picks it up, and ideally beyond. That means addressing gaps that electronic prescribing alone has left unresolved, particularly around transparency, flexibility, and real-time coordination.

A decade of digital transformation in healthcare has yielded progress. Industry estimates indicate that the global e-prescribing sector was valued at $3.36 billion in 2025 and is expected to expand significantly over the coming years, with projections placing the market above $14 billion by 2034, reflecting sustained double-digit annual growth. Yet beneath these adoption figures, critical challenges can persist. “Prescriptions often arrive as static messages that are difficult to reroute or update when circumstances change,” Stephen McGee, Executive Vice President and Chief Compliance Officer of TransferMyRx, says. “Under current regulations, transfers typically require licensed pharmacists to rely on time-intensive phone calls or fax exchanges, which can disrupt workflow, slow patients down, and divert clinicians’ attention away from direct care.”

Stephen notes that this fragmentation has created a kind of prescription pipeline where the message travels, but the journey frequently stalls. In his view, the missing layer is a foundational infrastructure engineered to support every player in the ecosystem, providers, pharmacies, payers, and patients alike. “A successful model should function within existing regulatory expectations while unlocking new workflow capabilities that have historically been inaccessible,” Stephen says. 

At the core of this vision is a hybrid prescription transfer system that blends digital efficiency with the legal realities of pharmacy practice. Instead of fully closed networks or solutions that require each pharmacy to integrate via APIs, this hybrid approach mimics the legal requirements for pharmacist-to-pharmacist transfer in a digital send-and-accept workflow. Rather than forcing every participant onto the same technical stack, the system creates a universal layer that can interoperate across heterogeneous infrastructures. Stephen explains that this architecture is designed to accelerate transfers and reduce friction without demanding wholesale replacement of the existing system.

The broader context for this work is a healthcare system under pressure. Prescription drug prices in the U.S. have risen sharply, posting increases of 37 percent since 2014, placing added strain on patients and payers alike. “High costs and operational inefficiencies can make affordability challenges even more difficult by delaying access or complicating medication adherence,” Nabil says. “By reframing the prescription journey as an infrastructure issue, the goal is to reduce those secondary pressures and create a clearer path to improved access and outcomes.”

Restoring patient control is another central tenet of the approach. Nabil notes that the TransferMyRx platform is being developed to give patients clearer insight into what has been prescribed and where it is in the fulfillment process. Features such as universal product locators and transparent transfer tools aim to shift agency back toward the patient, helping address a persistent disconnect between clinical intent and real-world access.

“Many clinicians feel their role ends once a prescription is sent, yet unresolved issues often lead to follow-up calls and added administrative work,” Stephen explains. “More reliable infrastructure could help reduce that friction and allow providers to stay focused on patient care.”

According to Stephen, this vision also casts a longer horizon of a future in which prescriptions initiated in one jurisdiction can be safely and legally maintained across borders, accommodating travel or relocation without forcing patients to restart the process. “While such global continuity remains a long-term aspiration, it underscores the potential strategic value of building prescription systems as interoperable infrastructure rather than siloed features,” he notes. 

Healthcare’s next era will likely be defined by infrastructures that mirror those in fintech or logistics, systems that operate invisibly beneath the surface while enabling every stakeholder to move with confidence. Nabil says, “When the rails work properly, innovation stops being a bottleneck and starts becoming a natural outcome of how the system operates.”This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.